Home > Healthcare > Medical Devices > Therapeutic Devices > Adhesion Barrier Market
Based on product, the adhesion barrier market is bifurcated into natural adhesion barriers and synthetic adhesion barriers. The synthetic adhesion barriers segment was valued at around USD 366.4 million in 2022. The high segmental expansion is attributed to availability of robust product portfolio specific to synthetic category including hyaluronic acid, regenerated cellulose, among others. Synthetic adhesion barriers are cost-effective in nature and can hold significant amount of moisture, thus improving the product safety and efficacy. Synthetic barriers are resorbable in nature, thereby eliminating the need for implant removing surgery.
Based on formulation, the adhesion barrier market is categorized into film/mesh, gel, and liquid. The film/mesh segment was valued at around USD 281.5 million in 2022. Increasing adoption of film form barriers in different surgeries owing to supportive clinical evidence is projected to fuel the industry revenue. Further, low-cost availability of mesh products with proper safety and efficiency is anticipated to contribute to product adoption over the analysis period. Factors such as ease of use and high adoption of these products by surgeons in comparison to gel and liquid form of barriers is further adding to market demand.
Based on application, the adhesion barrier market is segmented into gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, general/abdominal surgeries, urological surgeries and others. The cardiovascular surgeries segment is anticipated to witness the fastest evolution with a CAGR of 8.2% by 2032. Consistent rise in incidence and prevalence of heart-related disorders is anticipated to spur the adoption of adhesive barriers in cardiovascular surgeries. For instance, as per the data reported by National Heart, Lung, and Blood Institute, over 2 million people have open-heart surgery globally. Additionally, use of adhesion barriers in cardiovascular surgeries prove beneficial in preventing the formation of peristomal adhesion.
North America adhesion barrier market is expected to reach around USD 493.5 million in 2032. Presence of significant patient pool related to different diseases including gynecology, neurology, and orthopedic conditions among others is expected to be a key driving factor for regional progression. For instance, as per the data reported by The Johns Hopkins University, around 500,000 hysterectomies are performed each year in the U.S. Moreover, according to the National Institutes of Health data, around 4 million gynecologic surgeries are performed in the U.S. annually.
Furthermore, approximately around 7 million orthopedic surgeries are performed in the country. Thus, such high surgical volume necessitates the adoption of adhesive barriers, thereby supporting the market growth. Also, rise in R&D activities for development of technologically advanced novel products is expected to contribute to increased product adoption.